HOME ABOUT US PRINT PUBLICATIONS SUBSCRIPTIONS CONTACT US RSS
 
Welcome to FDAweb
Pay Per View
Search our 49,999 - story database FREE
 
Free Items
 Warning Letters
 FDA Notices
 FDA Calendar
 

 FDA Whistleblowers



    








 
     
 
Panel to Discuss Donor Deferral to Reduce Creutzfeldt-Jakob Disease
07/01/2011
 

Federal Register Notice: FDA’s Transmissible Spongiform Encephalopathies Advisory Committee will meet 8/1, from 9 a.m. to about 4:30 p.m. at the Hilton Hotel, Washington DC North Gaithersburg, 620 Perry Pkwy., Gaithersburg, MD. The committee will discuss donor deferral for time spent in Saudi Arabia to reduce the risk of variant Creutzfeldt-Jakob disease by blood and blood products and human cells, tissues and cellular and tissue-based products. Contact Bryan Emery or Rosanna Harvey, (301) 827-0314. To view this notice, click here.

 
 
 
Any copying or electronic transfer without written permission is strictly prohibited and will result
in termination of service and prosecution under the federal Copyright Act.
To gain permission to copy this article log on to http://www.copyright.com.

FERDIC INCORPORATED - P.O. Box 28, Camp Hill, PA 17001 | Phone: (717)731-1426 fax:(717)731-1427 Email: info@fdaweb.com